XML 47 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation (Tables)
 9 Months Ended
Oct. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
The following table details share-based compensation expense and the related income tax impacts for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019:
Thirteen Weeks EndedThirty-nine Weeks Ended
(in thousands)October 31, 2020November 2, 2019October 31, 2020November 2, 2019
Share-based compensation expense$4,669 $5,796 $13,575 $8,464 
Income tax benefit associated with share-based compensation expense recognized (1)
$— $1,211 $— $1,566 
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block]
The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019:
Thirteen Weeks EndedThirty-nine Weeks Ended
(in thousands)October 31, 2020November 2, 2019October 31, 2020November 2, 2019
Income tax discrete benefits realized for tax deductions related to the issuance of shares (1)
$— $6 $— $1,175 
Income tax discrete charges realized upon cancellation of stock appreciation rights (1)
— (447)— (611)
Total income tax discrete (charges) benefits related to share-based compensation awards$— $(441)$— $564 
Schedule of Restricted Stock Unit Activity
The following table summarizes activity for restricted stock units for the thirty-nine weeks ended October 31, 2020:
Service-based Restricted
Stock Units		Performance-based Restricted
Stock Units		Market-based Restricted
Stock Units
Number of 
Underlying
Shares (1)
Weighted-
Average Grant
Date Fair Value		Number of 
Underlying
Shares		Weighted-
Average Grant
Date Fair Value		Number of 
Underlying
Shares		Weighted-
Average Grant
Date Fair Value
Unvested at February 1, 20201,676,831 $18.68 747,056 $15.11 421,784 $23.05 
Granted2,280,194 8.57 — — 519,905 16.24 
Adjustments for performance achievement
— — 38,381 11.37 134,122 11.79 
Vested(790,429)17.42 (481,304)9.63 (350,447)11.79 
Forfeited(107,795)13.83 (6,917)22.80 (3,485)35.61 
Unvested at October 31, 2020 (2)
3,058,801 $11.63 297,216 $22.43 721,879 $21.46 
(1)    Includes 66,624 unvested restricted stock units as of October 31, 2020, subject to vesting requirements related to the achievement of certain performance metrics, such as operating income and net income, for the fiscal year immediately preceding the vesting date. Holders of these restricted stock units have the opportunity to earn back one or more installments of the award if the cumulative performance requirements are met in a subsequent year.
(2)    Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Certain unvested shares related to restricted stock units with performance-based vesting conditions can be achieved at up to 200% of their target vesting amount.
Schedule of Stock Appreciation Rights Activity
The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended October 31, 2020:
Number of
Underlying
Shares		Weighted-Average
Exercise Price		Aggregate
Intrinsic Value		Weighted-Average
Remaining
Contractual Life (years)
Outstanding at February 1, 2020796,725 $40.06 
Granted— — 
Exercised— — 
Forfeited or expired(382,225)47.87 
Outstanding at August 1, 2020414,500 $32.86 $— 3.2
Stock appreciation rights exercisable at October 31, 2020414,500 $32.86 $— 3.2
Stock appreciation rights expected to become exercisable in the future as of October 31, 2020— $— $— 0.0

No stock appreciation rights were exercised during the thirty-nine weeks ended October 31, 2020. Additional information pertaining to stock appreciation rights for the thirty-nine weeks ended November 2, 2019 follows:
(in thousands)November 2, 2019
Total grant date fair value of awards exercised$620 
Market-based restricted stock units [Member]  
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions
Additional information pertaining to restricted stock units for the thirty-nine weeks ended October 31, 2020 and November 2, 2019 follows:
(in thousands)October 31, 2020November 2, 2019
Service-based restricted stock units:
Total grant date fair value of awards granted$19,541 $16,175 
Total grant date fair value of awards vested$13,769 $13,087 
Performance-based restricted stock units:
Total grant date fair value of awards granted$— $5,379 
Total grant date fair value of awards vested$4,635 $— 
Market-based restricted stock units:
Total grant date fair value of awards granted$8,443 $4,176 
Total grant date fair value of awards vested$4,132 $511 
The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended October 31, 2020 and November 2, 2019, respectively, were as follows:
October 31, 2020November 2, 2019
Grant date market price$12.31 $25.34 
Fair value$16.24 $36.24 
Assumptions:
Price volatility67 %57 %
Expected term (years)2.42.9
Risk-free interest rate0.2 %2.2 %
Dividend yield— %3.2 %
Average volatility of peer companies66.0 %40.0 %
Average correlation coefficient of peer companies0.49670.2407